Metreleptin
- Generic Name
- Metreleptin
- Brand Names
- Myalept, Myalepta
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 186018-45-1
- Unique Ingredient Identifier
- TL60C27RLH
- Background
Metreleptin, a recombinant analog of the human hormone leptin, is an orphan drug used to treat complications of leptin deficiency in people with congenital or acquired lipodystrophy. Affecting less than 500 people worldwide, lipodystrophy is characterized by a lack of adipose tissue, fat deposition in the muscles and liver, and metabolic complications such a...
- Indication
Metreleptin is indicated as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.
- Associated Conditions
- Congenital leptin deficiency
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath